Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
Publication/Presentation Date
1-1-2017
Abstract
Inflammation and autophagy have emerged as prominent issues in the context of proteoglycan signaling. In particular, two small, leucine-rich proteoglycans, biglycan and decorin, play pivotal roles in the regulation of these vital cellular pathways and, as such, are intrinsically involved in cancer initiation and progression. In this minireview, we will address novel functions of biglycan and decorin in inflammation and autophagy, and analyze new emerging signaling events triggered by these proteoglycans, which directly or indirectly modulate these processes. We will critically discuss the dual role of proteoglycan-driven inflammation and autophagy in tumor biology, and delineate the potential mechanisms through which soluble extracellular matrix constituents affect the microenvironment associated with inflammatory and neoplastic diseases.
Volume
284
Issue
1
First Page
10
Last Page
26
ISSN
1742-4658
Published In/Presented At
Schaefer, L., Tredup, C., Gubbiotti, M. A., & Iozzo, R. V. (2017). Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. The FEBS journal, 284(1), 10–26. https://doi.org/10.1111/febs.13963
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27860287
Department(s)
Administration and Leadership
Document Type
Article